Cite

    Zhang, W. et al. (n.d.). Dihydromyricetin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro partially via the activation of Wnt/β‐catenin signaling pathway. Fundamental & clinical pharmacology. pp. 596-606. [Online].